Newsbenzinga
What's Going on with Vera Therapeutics Stock on Monday?
· Published
Article summary
Vera Therapeutics awaits the FDA's July 7 decision on atacicept for IgA nephropathy as investors weigh trial data and competition from Novartis.
An excerpt from the original article.
Comments —
Loading comments…